An Update on Topical Therapies for Mild-Moderate Psoriasis
- 1 January 2015
- journal article
- review article
- Published by Elsevier in Dermatologic Clinics
- Vol. 33 (1) , 73-77
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A randomized phase 2a efficacy and safety trial of the topical J anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasisBritish Journal of Dermatology, 2013
- Treatment of scalp psoriasis with clobetasol‐17 propionate 0.05% shampoo: a study on daily clinical practiceJournal of the European Academy of Dermatology and Venereology, 2010
- Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasisJournal of Dermatological Treatment, 2010
- Topical Clobetasol Propionate in the Treatment of PsoriasisAmerican Journal of Clinical Dermatology, 2009
- Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trialBritish Journal of Dermatology, 2009
- A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp PsoriasisDermatology, 2008
- Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasisJournal of the American Academy of Dermatology, 2005
- Safety and Efficacy of Fluticasone Propionate in the Topical Treatment of Skin DiseasesSkin Pharmacology and Physiology, 2004
- The Efficacy and Tolerability of Clobetasol Propionate Foam 0.05% in the Treatment of Mild to Moderate Plaque-type Psoriasis of Nonscalp RegionsJournal of Cutaneous Medicine and Surgery, 2003
- Clinical experience with topical calcitriol (1,25-dihydroxy-vitamin D3) in psoriasisBritish Journal of Dermatology, 2001